In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tessa Pugh, ex-CEO & Co-Founder at PharmaReview.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tessa, covering:
How Tessa's bullish attitude led to her becoming a co-founder at PharmaReview
Being the 'less educated person in the office', and using that to drive the growth of the business
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tessa Pugh, ex-CEO & Co-Founder at PharmaReview.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tessa, covering:
- How Tessa's bullish attitude led to her becoming a co-founder at PharmaReview
- Being the 'less educated person in the office', and using that to drive the growth of the business
- Opting not to leave after the sale of the business, and becoming the CEO
- Being the star player within a PE portfolio, leading to a quick exit to IQVIA
- Life lessons on having your cake...and eating it!
Tessa Pugh is the former CEO & Co-founder PharmaReview, a Mum and an athlete. She spent 13 years working with Pharma companies and their agencies; she Co-Founded PharmaReview in 2011. Tessa was responsible for ensuring excellent client service, business development for both new and existing clients. She is a Pharma copy review process expert and became an expert in Veeva Vault functionality.
Prior to this, she established a luxury direct-to-consumer cupcake company and worked in client service at some of the world’s leading advertising agencies including Saatchi & Saatchi and DRAFT. She is a very proud Mum to two incredible young women. Tessa has completed several marathons; has competed in triathlons and has won an age group national title in track cycling. She is currently following a life-long dream and training to be a ski instructor.
This episode of Molecule to Market is sponsored by Vetter, a global leader in aseptic filling solutions for injectable products in the pharmaceutical and biotech industries. Discover more about Vetter’s comprehensive services, from early-stage development to commercial production, and how they support clients in delivering high-quality therapies to the market.
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.
View more
